Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

RGEN

Repligen Corp

Oct 22 • 04:00PM ET

157.41

+0.66 0.42 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: IJH VTI VB VBK VXF MDY IBB FBT SPMD IWR

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	5.52%	Shs Outstand	56.25M	Perf Week	5.28%
Market Cap	8.86B	Forward P/E	71.80	EPS next Y	2.19	Insider Trans	-1.70%	Shs Float	53.15M	Perf Month	26.99%
Enterprise Value	8.83B	PEG	-	EPS next Q	0.42	Inst Own	98.31%	Short Float	6.42%	Perf Quarter	29.16%
Income	-13.83M	P/S	13.14	EPS this Y	6.63%	Inst Trans	-3.26%	Short Ratio	3.69	Perf Half Y	11.32%
Sales	673.96M	P/B	4.29	EPS next Y	30.14%	ROA	-0.48%	Short Interest	3.41M	Perf YTD	9.36%
Book/sh	36.65	P/C	12.49	EPS next 5Y	21.56%	ROE	-0.68%	52W High	182.52 -13.76%	Perf Year	7.12%
Cash/sh	12.60	P/FCF	83.58	EPS past 3/5Y	- -	ROIC	-0.51%	52W Low	102.96 52.88%	Perf 3Y	-23.08%
Dividend Est.	-	EV/EBITDA	63.54	Sales past 3/5Y	-1.83% 18.61%	Gross Margin	46.16%	Volatility	3.47% 4.01%	Perf 5Y	-7.41%
Dividend TTM	-	EV/Sales	13.11	EPS Y/Y TTM	-245.82%	Oper. Margin	4.10%	ATR (14)	5.83	Perf 10Y	535.49%
Dividend Ex-Date	-	Quick Ratio	7.32	Sales Y/Y TTM	8.73%	Profit Margin	-2.05%	RSI (14)	70.36	Recom	1.46
Dividend Gr. 3/5Y	- -	Current Ratio	8.59	EPS Q/Q	159.98%	SMA20	8.25%	Beta	1.13	Target Price	181.11
Payout	-	Debt/Eq	0.33	Sales Q/Q	14.81%	SMA50	20.09%	Rel Volume	1.30	Prev Close	156.75
Employees	1778	LT Debt/Eq	0.32	Earnings	Oct 28 BMO	SMA200	16.56%	Avg Volume	924.40K	Price	157.41
IPO	Apr 29, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	-4.69% 4.10%	Trades		Volume	1,205,429	Change	0.42%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-25	Initiated	HSBC Securities	Buy	$150
Sep-22-25	Upgrade	Evercore ISI	In-line → Outperform	$155
Jul-22-25	Resumed	Stephens	Overweight	$160
Jun-24-25	Initiated	Barclays	Overweight	$150
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330

Show Previous Ratings

Oct-21-25 11:40AM	ALKS vs. RGEN: Which Stock Is the Better Value Option? (Zacks)
10:00AM	Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-15-25 07:30AM	Repligen to Report Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-09-25 07:46AM	Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? (Insider Monkey)
Oct-01-25 12:20PM	Why Is Repligen (RGEN) Stock Soaring Today (StockStory) +9.08%
04:05PM	Loading…
Sep-30-25 04:05PM	Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know (StockStory) +7.72%
Sep-24-25 12:04AM	3 Reasons to Sell RGEN and 1 Stock to Buy Instead (StockStory)
Sep-22-25 11:31PM	Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN) (StockStory)
Sep-16-25 02:51PM	Repligen (RGEN) Stock Is Up, What You Need To Know (StockStory) +5.28%
Sep-12-25 02:26PM	Why Repligen (RGEN) Stock Is Down Today (StockStory)
Aug-22-25 03:40PM	Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know (StockStory)
07:30AM	Repligen Corporation to Present at Upcoming September Conferences (GlobeNewswire)
Aug-20-25 08:42AM	Do Options Traders Know Something About Repligen Stock We Don't? (Zacks)
Aug-12-25 12:53AM	RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty (StockStory) +8.51%
12:35AM	5 Must-Read Analyst Questions From Repligen's Q2 Earnings Call (StockStory)
09:45AM	Loading…
Aug-07-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-31-25 07:30AM	Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization (GlobeNewswire)
Jul-29-25 11:52PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:26PM	Why Repligen (RGEN) Stock Is Up Today (StockStory)
08:45AM	Repligen (RGEN) Lags Q2 Earnings Estimates (Zacks)
08:09AM	Repligen's (NASDAQ:RGEN) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic (StockStory)
07:41AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Jul-28-25 09:22AM	Repligen Corp (RGEN) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-27-25 11:06PM	Repligen (RGEN) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-22-25 09:40AM	Netflix downgraded, Intel initiated: Wall Street's top analyst calls (The Fly)
Jul-21-25 09:45AM	Here's Why Repligen (RGEN) is a Strong Growth Stock (Zacks)
Jul-18-25 03:11PM	Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know (StockStory) -6.28%
12:03AM	3 Reasons RGEN is Risky and 1 Stock to Buy Instead (StockStory)
Jul-17-25 07:30AM	Repligen to Report Second Quarter 2025 Financial Results (GlobeNewswire)
02:18PM	Loading…
Jun-24-25 02:18PM	5 Insightful Analyst Questions From Repligen's Q1 Earnings Call (StockStory)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-04-25 11:36PM	Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-03-25 11:32PM	Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers (StockStory)
Jun-02-25 01:36PM	Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? (Zacks)
May-29-25 11:30AM	Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? (Zacks)
May-27-25 07:30AM	Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report (GlobeNewswire)
May-22-25 07:30AM	Repligen Corporation to Present at William Blair Growth Conference (GlobeNewswire)
May-09-25 12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-07-25 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
08:18AM	Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare (Insider Monkey)
May-01-25 12:11PM	Jim Cramer on Repligen Corporation (RGEN): 'I'm Not Quite Ready to Stick My Neck Out on This One' (Insider Monkey)
Apr-30-25 04:19PM	RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty (StockStory)
10:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
09:07AM	Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
03:09AM	Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
12:58PM	Repligen Corporation (RGEN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:05AM	Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:45AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 07:08PM	What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings (GuruFocus.com)
03:08AM	Repligen (RGEN) Q1 Earnings: What To Expect (StockStory)
Apr-25-25 09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:01AM	Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) +5.54%
Apr-16-25 11:40AM	GMAB or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
Apr-15-25 07:30AM	Repligen to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-10-25 05:03AM	Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -6.99%
Apr-08-25 07:30AM	Repligen Appoints Jacob Johnson As Vice President Investor Relations (GlobeNewswire) -6.22%
04:11AM	Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-25-25 12:46PM	Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? (Insider Monkey)
Mar-20-25 07:52AM	Repligen: Ongoing Bioprocessing Market Recovery (SeekingAlpha)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:01AM	Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks (StockStory)
Mar-11-25 05:01AM	A Look Back at Drug Development Inputs & Services Stocks Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack (StockStory) +7.40%
Mar-10-25 08:06PM	Analyst Report: Repligen Corporation (Morningstar Research) -12.02%
Mar-06-25 08:02AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Mar-05-25 05:14AM	Q4 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Mar-04-25 01:26PM	908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth (Benzinga)
07:30AM	Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices (Business Wire)
Feb-21-25 04:28PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:06AM	Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:24AM	Q4 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-20-25 07:21PM	Analyst Report: Repligen Corporation (Morningstar Research) +7.92%
02:00PM	Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook (Benzinga)
08:54AM	What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings (GuruFocus.com)
08:45AM	Repligen (RGEN) Beats Q4 Earnings Estimates (Zacks)
08:08AM	Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates (StockStory)
07:50AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-19-25 08:05AM	Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow (StockStory)
Feb-12-25 08:44PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:17AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Feb-11-25 07:30AM	Repligen to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-29-25 03:19AM	Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains? (Zacks)
Jan-13-25 07:18PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-07-25 07:30AM	Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-06-25 07:30AM	Repligen Launches the CTech SoloVPE PLUS System (GlobeNewswire)
Dec-20-24 09:21AM	Repligen Corporation (RGEN) Fell Along with Peers (Insider Monkey)
Dec-18-24 09:40PM	Analyst Report: Repligen Corporation (Morningstar Research) -6.83%
Dec-16-24 07:43PM	Analyst Report: Repligen Corporation (Morningstar Research)
08:11AM	BioLife Solutions Appoints Tony J. Hunt to its Board of Directors (PR Newswire)
Dec-12-24 11:30AM	Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? (Zacks)
07:30AM	Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report (GlobeNewswire)
Dec-09-24 09:03AM	Several Factors Lifted Repligen Corporation (RGEN) in Q3 (Insider Monkey)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunt Anthony	Director	Sep 10 '25	Option Exercise	33.87	20,000	677,400	129,854	Sep 11 02:55 PM
Hunt Anthony	Director	Sep 10 '25	Sale	120.52	29,111	3,508,389	100,743	Sep 11 02:55 PM
Hunt Anthony	Director	Sep 10 '25	Proposed Sale	120.52	29,111	3,508,378		Sep 10 04:22 PM
Madaus Martin D	Director	Aug 08 '25	Buy	112.13	1,800	201,830	1,800	Aug 12 12:47 PM
Hunt Anthony	Director	May 15 '25	Sale	123.71	26,447	3,271,688	109,854	May 16 03:02 PM
Hunt Anthony	Director	May 15 '25	Proposed Sale	128.34	26,447	3,394,208		May 15 10:25 AM
Hunt Anthony	Director	Mar 17 '25	Option Exercise	54.73	26,756	1,464,267	163,057	Mar 19 04:21 PM
Hunt Anthony	Director	Mar 17 '25	Sale	152.51	26,756	4,080,663	136,301	Mar 19 04:21 PM
Pax Margaret	Director	Mar 17 '25	Buy	150.69	250	37,672	1,043	Mar 18 03:58 PM
Hunt Anthony	Director	Mar 17 '25	Proposed Sale	150.42	26,756	4,024,638		Mar 17 10:04 AM
Hunt Anthony	Director	Dec 05 '24	Option Exercise	33.87	11,808	399,937	151,648	Dec 05 08:26 PM
Hunt Anthony	Director	Nov 21 '24	Option Exercise	33.87	24,246	821,212	164,086	Nov 22 04:52 PM
Hunt Anthony	Director	Nov 21 '24	Sale	139.67	24,246	3,386,439	139,840	Nov 22 04:52 PM
Anthony Hunt	Executive Chairman	Nov 21 '24	Proposed Sale	139.66	24,246	3,386,311		Nov 21 03:52 PM
MUIR GLENN P	Director	Nov 19 '24	Option Exercise	36.29	19,000	689,510	32,283	Nov 20 02:29 PM

Open in Screener

QTRX

Quanterix Corp

Oct 22 • 04:00PM ET

5.75

-0.31 -5.12 %

Healthcare • Medical Devices • USA • NASD

Peers: ILMN NTRA TWST GH EXAS TMO ABT DHR BIO QGEN

| Held by: VTI IWM VXF IWN IBB SCHA VTWO FESM VHT IWC

Index	RUT	P/E	-	EPS (ttm)	-1.82	Insider Own	12.90%	Shs Outstand	46.47M	Perf Week	-0.52%
Market Cap	267.18M	Forward P/E	-	EPS next Y	-1.27	Insider Trans	9.36%	Shs Float	40.47M	Perf Month	5.70%
Enterprise Value	41.54M	PEG	-	EPS next Q	-0.46	Inst Own	74.95%	Short Float	10.08%	Perf Quarter	4.36%
Income	-70.50M	P/S	2.12	EPS this Y	-105.37%	Inst Trans	-1.48%	Short Ratio	6.59	Perf Half Y	7.68%
Sales	125.78M	P/B	0.76	EPS next Y	38.20%	ROA	-17.81%	Short Interest	4.08M	Perf YTD	-45.91%
Book/sh	7.52	P/C	1.02	EPS next 5Y	6.78%	ROE	-22.27%	52W High	15.67 -63.31%	Perf Year	-55.01%
Cash/sh	5.62	P/FCF	-	EPS past 3/5Y	14.43% 9.19%	ROIC	-21.84%	52W Low	4.05 41.98%	Perf 3Y	-34.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.52% 19.36%	Gross Margin	58.53%	Volatility	5.53% 5.75%	Perf 5Y	-86.67%
Dividend TTM	-	EV/Sales	0.33	EPS Y/Y TTM	-96.96%	Oper. Margin	-62.60%	ATR (14)	0.33	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.06	Sales Y/Y TTM	-2.74%	Profit Margin	-56.05%	RSI (14)	52.94	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.68	EPS Q/Q	-300.47%	SMA20	0.34%	Beta	1.11	Target Price	6.25
Payout	-	Debt/Eq	0.12	Sales Q/Q	-28.81%	SMA50	10.88%	Rel Volume	0.61	Prev Close	6.06
Employees	471	LT Debt/Eq	0.10	Earnings	Aug 07 AMC	SMA200	-8.53%	Avg Volume	618.63K	Price	5.75
IPO	Dec 07, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-82.25% -13.29%	Trades		Volume	376,923	Change	-5.12%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-25	Downgrade	Canaccord Genuity	Buy → Hold	$5
Feb-01-24	Initiated	Scotiabank	Sector Outperform	$30
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy	$25 → $32
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform	$30
May-23-23	Upgrade	Goldman	Neutral → Buy	$13 → $27
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold	$40 → $12
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$35 → $15
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform	$38 → $18
Mar-02-22	Upgrade	Goldman	Sell → Neutral	$40
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell	$53

Show Previous Ratings

Oct-02-25 12:00PM	All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy (Zacks)
Aug-21-25 04:30PM	Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit (Business Wire)
Aug-12-25 09:35AM	Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX) (Zacks)
Aug-11-25 07:00AM	Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Aug-07-25 06:35PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -13.79%
04:06PM	Loading…
04:06PM	Quanterix Releases Financial Results for the Second Quarter of 2025 (Business Wire)
Aug-04-25 04:02PM	Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
09:30AM	Quanterix Announces Cooperation Agreement with Kent Lake Capital (Business Wire)
Jul-28-25 07:00AM	Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC (Business Wire) +10.94%
Jul-24-25 08:45AM	Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock? (Zacks)
Jul-11-25 05:00PM	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-08-25 09:07AM	Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum (Business Wire)
Jun-23-25 07:30AM	Quanterix Expands Reach with IVD and Large Reference Labs (Business Wire)
Jun-11-25 08:00AM	Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders (PR Newswire)
Jun-06-25 09:41AM	Quanterix to Present at Goldman Sachs Global Healthcare Conference (Business Wire)
02:21PM	Loading…
May-23-25 02:21PM	Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal (PR Newswire)
09:10AM	New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs (PR Newswire)
May-13-25 03:09AM	Quanterix Corp (QTRX) Q1 2025 Earnings Call Highlights: Record Consumables Revenue Amidst ... (GuruFocus.com) -19.02%
May-12-25 05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +8.52%
04:01PM	Quanterix Releases Financial Results for the First Quarter of 2025 (Business Wire)
May-09-25 09:42AM	Earnings To Watch: Quanterix Corp (QTRX) Reports Q1 2025 Result (GuruFocus.com)
May-07-25 07:40PM	Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates (Zacks)
May-05-25 07:00AM	Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025 (Business Wire)
Apr-30-25 08:00AM	Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders (Business Wire)
Apr-29-25 07:00AM	Quanterix and Akoya Biosciences Announce Amended Merger Agreement (Business Wire)
Apr-17-25 08:30AM	Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders (Business Wire)
Apr-14-25 08:00AM	Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences (Business Wire) +7.69%
Apr-07-25 08:15AM	Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya (Business Wire) -12.96%
Apr-02-25 09:41AM	Quanterix: Still Many, Many Questions (Seeking Alpha)
Apr-01-25 01:00AM	Quanterix Showcases Innovation Powered by Simoa at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit (Business Wire)
11:03AM	Loading…
Mar-24-25 11:03AM	Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences (Business Wire)
Mar-19-25 04:10PM	SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN (PR Newswire)
Mar-18-25 09:18AM	Q4 2024 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)
03:01AM	Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
Mar-17-25 04:01PM	Quanterix Releases Financial Results for the Fourth Quarter of 2024 (Business Wire)
04:00PM	Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Todays Earnings Call (Business Wire)
04:00PM	Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results (GlobeNewswire)
Mar-13-25 01:00PM	Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 (Business Wire)
Mar-11-25 08:00AM	Kent Lake Issues Investor Presentation Detailing Opposition to Quanterixs Proposed Merger with Akoya Biosciences (Business Wire)
Mar-03-25 08:00AM	Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board (Business Wire) -6.59%
06:00AM	Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition (Business Wire)
Feb-18-25 03:40PM	Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Companys Proposed Merger with Akoya Biosciences (Business Wire)
Jan-14-25 07:00AM	Quanterix Provides Update on Financial Performance (Business Wire) -5.93%
Jan-10-25 07:00AM	Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers (Business Wire) -19.69%
Jan-06-25 09:30AM	David R. Walt Receives National Medal of Technology and Innovation (Business Wire)
Jan-02-25 04:26PM	Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +12.27%
Dec-27-24 04:33AM	Down More Than 60%: Analysts Expect These 2 Beaten-Down Stocks to Rebound in 2025 (TipRanks)
Dec-17-24 06:59AM	Quanterix Expands Capabilities with Strategic Acquisition of EMISSION (Business Wire)
Nov-22-24 05:00PM	Quanterix Announces Receipt of Expected Notice from Nasdaq (Business Wire) +5.70%
07:54AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (GlobeNewswire)
Nov-21-24 07:00AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (PR Newswire) +6.35%
Nov-13-24 02:18AM	Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ... (GuruFocus.com) -18.26%
Nov-12-24 04:01PM	Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 (Business Wire)
Nov-11-24 07:14AM	Quanterix Corp (QTRX) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-05-24 04:00PM	Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024 (Business Wire) +5.99%
Oct-28-24 04:30PM	New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information (Business Wire) +5.02%
Oct-09-24 05:55PM	Quanterix Corp (QTRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Regional ... (GuruFocus.com)
Oct-02-24 04:00PM	Quanterix Welcomes Ivana Magovevi-Liebisch, Ph.D., J.D. to Board of Directors (Business Wire)
Sep-30-24 04:00PM	Quanterix Announces Commercialization of p-Tau 217 Test Kit (Business Wire)
Aug-29-24 04:00PM	Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-19-24 04:32PM	Jeffrey Elliott Appointed to Quanterixs Board of Directors (Business Wire) +7.66%
Aug-15-24 07:18PM	Insider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX) (GuruFocus.com) +9.25%
Aug-08-24 05:10PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -14.82%
04:00PM	Quanterix Releases Financial Results for the Second Quarter of 2024 (Business Wire)
Aug-06-24 04:00PM	Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference (Business Wire) -5.26%
Jul-31-24 04:00PM	Quanterix To Report Second Quarter 2024 Financial Results (Business Wire)
Jul-29-24 10:00AM	Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for (Zacks) -6.62%
08:00AM	Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimers Disease Detection that is More Effective than Standalone Plasma p-Tau 217 (Business Wire)
Jun-17-24 04:00PM	Quanterix to Participate at the Scotiabank Healthcare 1x1 Day (Business Wire) +5.48%
Jun-05-24 04:00PM	Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference (Business Wire)
May-22-24 04:00PM	Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 (Business Wire)
May-15-24 09:55AM	Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade (Zacks) +6.30%
May-09-24 04:45PM	Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:10AM	Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ... (GuruFocus.com)
May-07-24 09:00PM	QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Financial Results for the First Quarter of 2024 (Business Wire)
Apr-29-24 04:00PM	Quanterix To Report First Quarter 2024 Financial Results (Business Wire)
11:13AM	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating (MT Newswires)
Mar-21-24 05:30PM	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure (Business Wire)
Mar-06-24 09:50AM	Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag (Zacks)
Mar-04-24 09:00AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimers Disease (Business Wire)
Mar-03-24 08:16AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:26AM	Q4 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) +12.69%
Feb-29-24 05:10PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 (Business Wire)
Feb-27-24 10:03AM	Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances (Zacks)
06:34AM	Quanterix Corp (QTRX) Aligns Earnings Release with Annual Report Filing, Reaffirms 2023 Guidance (GuruFocus.com)
Feb-26-24 09:00AM	Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimers Disease (Business Wire)
Feb-23-24 04:30PM	Quanterix to Present at Cowens 44th Annual Health Care Conference (Business Wire)
Feb-16-24 04:00PM	Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call (Business Wire)
Dec-12-23 04:00PM	Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +8.77%
Dec-04-23 12:00PM	Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy (Zacks)
Nov-29-23 09:55AM	Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect? (Zacks)
Nov-13-23 04:00PM	Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) +9.47%
09:55AM	Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High? (Zacks)
07:00AM	Sotera Health Appoints Karen Flynn to Board of Directors (GlobeNewswire)
Nov-08-23 12:22PM	Quanterix Corporation (NASDAQ:QTRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:40PM	Quanterix Corp (QTRX) Raises Full-Year Revenue Expectations Following Q3 2023 Results (GuruFocus.com)
05:30PM	7 Stocks to Buy if You Anticipate a Hot November (InvestorPlace)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sriram Vandana	Chief Financial Officer	Sep 12 '25	Buy	4.79	4,150	19,878	87,200	Sep 17 10:24 AM
WALT DAVID R	Director	Jun 13 '25	Buy	6.14	123,990	760,803	1,866,933	Jun 13 04:39 PM
WALT DAVID R	Director	Jun 12 '25	Buy	6.23	36,010	224,166	1,742,943	Jun 13 04:39 PM
Toloue Masoud	President & CEO	Jun 09 '25	Buy	5.42	45,900	248,723	518,922	Jun 10 04:08 PM
WALT DAVID R	Director	Jun 06 '25	Buy	5.43	131,869	716,576	1,628,802	Jun 09 05:44 PM
WALT DAVID R	Director	Jun 09 '25	Buy	5.34	78,131	417,220	1,706,933	Jun 09 05:44 PM
DONNELLY WILLIAM P	Director	Jun 06 '25	Buy	5.44	93,113	506,348	139,094	Jun 09 05:10 PM

RGEN

Repligen Corp

QTRX

Quanterix Corp

Upgrade your FINVIZ experience